Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 2 DiabetesPsychiatryIssue 681

Association between Smoking and Depression in Type 2 Patients

Smoking and depression are strongly associated in patients with type 2 diabetes....

Advertisement

The study population for the trial included a total of 1,868 adults with type 2 diabetes. Smoking was assessed in the study with five different categories which included: never, former, light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day). Depression was assessed and categorized in the study using a Patient Health Questionnaire. Depression was classified in a binary fashion in this study and patients were recorded as either having no major depression or major depression syndrome. To make sense of the relationship between individual's smoking activity and the presence of depression a statistical analysis using a logistic regression was used, while controlling for other demographic and health-related variables.

After the procedures of the study were carried out, the results showed that major depression was indeed associated with an augmented likelihood of being a smoker in any of the categories (light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day)). Depression; however, was also increased in the patients having 2 or more diabetes complications, moderate-severe disability or having 2 or more other chronic illnesses. In the fully adjusted study model, having major depression was associated with an increased likelihood of being a moderate or heavy smoker (odds ratio = 2.62, 95% confidence interval = 1.43–4.81). The statistical analysis from the study also showed that the association between a light smoker and major depression was not significant when adjusting for confounding variables.

Researchers concluded that smoking and depression are strongly associated in patients with type 2 diabetes. The association between smoking and the presence of major depression syndrome was strongest for diabetic patients classified as either moderate or heavy smokers. These findings potentially mean that depression may be a significant consideration when targeting clients with diabetes who continue to smoke and optimal mental health may not be obtainable until smoking cessation is achieved.

Matthew Clyde, Geneviève Smith, Norbert Gariépy, et al. Canadian Journal of Diabetes. Association between Smoking and Depression in a Canadian Community-Based Sample with Type 2 Diabetes. Vol. 37, Issue 3, June 4, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Past five issues: Issue 756 | Diabetes Clinical Mastery Series Issue 215 | SGLT-2 Inhibitors Special Edition November 2014 | Issue 755 | GLP-1 Special Editions November 2014 |

2014 Most Popular Articles:

Grapefruit Juice May Affect Insulin Resistance
Posted October 23, 2014
FDA Accepts Filing of NDA for Empagliflozin/Metformin Fixed-dose Combination
Posted October 23, 2014
New SGLT2 Inhibitor Likely To Be Approved for Type 2 Diabetes
Posted November 14, 2014
What's Hiding in that Insulin Box?
Posted October 27, 2014
Dietary Magnesium Intake's Role in Decreasing Metabolic Syndrome
Posted October 31, 2014
Handbook of Diabetes, 4th Ed., Excerpt #16: Diabetic Neuropathy
Posted November 02, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Very Low Carbohydrate, Low Saturated Fat Diet for Type 2 Diabetes Management
Posted November 07, 2014
Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 1
Posted November 02, 2014
Exenatide a Noninsulin Addition for Patients Failing Basal Insulin
Posted October 23, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
If the U.S. Affordable Care Act is reversed in the new congress, what impact will that have on your patients?
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5
Search Articles On Diabetes In Control